Mediators of Inflammation

Mediators of Inflammation / 2014 / Article
Special Issue

Actions of Allergens and Mediators in Allergy

View this Special Issue

Research Article | Open Access

Volume 2014 |Article ID 291618 |

Ying He, Xueting Liu, Yuyi Huang, Zehong Zou, Huifang Chen, He Lai, Lida Zhang, Qiurong Wu, Junyan Zhang, Shan Wang, Jianguo Zhang, Ailin Tao, Baoqing Sun, "Reduction of the Number of Major Representative Allergens: From Clinical Testing to 3-Dimensional Structures", Mediators of Inflammation, vol. 2014, Article ID 291618, 11 pages, 2014.

Reduction of the Number of Major Representative Allergens: From Clinical Testing to 3-Dimensional Structures

Academic Editor: Huiyun Zhang
Received10 Dec 2013
Accepted07 Feb 2014
Published23 Mar 2014


Vast amounts of allergen sequence data have been accumulated, thus complicating the identification of specific allergenic proteins when performing diagnostic allergy tests and immunotherapy. This study aims to rank the importance/potency of the allergens so as to logically reduce the number of allergens and/or allergenic sources. Meta-analysis of 62 allergenic sources used for intradermal testing on 3,335 allergic patients demonstrated that in southern China, mite, sesame, spiny amaranth, Pseudomonas aeruginosa, and house dust account for 88.0% to 100% of the observed positive reactions to the 62 types of allergenic sources tested. The Kolmogorov-Smironov Test results of the website-obtained allergen data and allergen family featured peptides suggested that allergen research in laboratories worldwide has been conducted in parallel on many of the same species. The major allergens were reduced to 21 representative allergens, which were further divided into seven structural classes, each of which contains similar structural components. This study therefore has condensed numerous allergenic sources and major allergens into fewer major representative ones, thus allowing for the use of a smaller number of allergens when conducting comprehensive allergen testing and immunotherapy treatments.

1. Introduction

Over the years, vast amounts of data regarding worldwide allergy diagnosis and treatment have been accumulated. More recently, allergen researchers have probed this data resulting in the complete cDNA sequencing of a large number of allergens, as well as the determination of their three-dimensional (3D) structure in some cases. However, systematic evaluation of the importance and/or potency of the allergens or their sources has not been investigated thus complicating the identification of specific allergenic proteins when performing diagnostic allergy tests. On the other hand, many patients react to a large number of proteins, and allergic cross-reactivity has been described on many levels [1]. The relatedness of pollen and plant food allergens was recently described based on sequence and/or structure similarity [2, 3], and many kinds of allergens were able to be classified into just a few protein families with a restricted number of biochemical functions [4].

Our previous results showed that 478 allergens retrieved online could be clustered into eight groups, regardless of their biological source [5]. It would be a desirable goal if extensive research on a large number of allergens could be transformed into intensive research on just a few major allergens, hereafter referred to as “representative allergens.” Major allergens are proteins that substantially bind to IgE from more than 50 percent of the patients with that specific allergy [6]. Major allergens have therefore been employed as internal standards in order to standardize allergen vaccines [7]. A detailed characterization of the importance of major allergens and their biological sources would allow for the improvement of allergen standardization and thus help to obtain more effective and safer modalities for the diagnosis and therapy of many allergic diseases.

In the present study, we reviewed our clinical intradermal test (IDT) data from 2001 to 2003 on 62 kinds of allergenic sources and compared the amino acid sequences and 3D structures of the major allergens obtained from different biological sources, with the goal of logically reducing these allergenic sources to a few species, as well as progressively clustering the 280 major allergens obtained from the ExPASy Proteomics Server (June 20, 2012) into several of the most representative major allergens. The results obtained could therefore facilitate more consistent and straightforward allergen research.

2. Methods

2.1. Allergic Patients and IDT

Over the past 32 years, we have intradermally tested (IDT) more than 90,000 patients referred to our allergy clinic. The IDT results of 62 allergen extracts on 3,335 patients in a three-year period (2001–2003) are shown in Figure 1 (children less than three years old were excluded). In our department, IDT has always been exhibited to be effective and safe and was reported to be diagnostically better than the skin prick test [8]. Nevertheless, informed consent for testing was obtained from all patients or their guardians, and the current study was approved by the Ethics Committee of the Second Affiliated Hospital of Guangzhou Medical University.

All allergens extracts were prepared in a sterile environment followed by toxicity and potency evaluation according to an in-house standard protocol as described [9]. After filtration to sterilize, protein levels were quantitated by the Kjeldahl Method [10]. The allergenicity of the extracts was further tested by mice assay to keep the consistency of different batches, followed by the adjustment of stock solution to the standard concentration. All extracts were aliquoted into 10 mL portions at a concentration of 1 : 10 or 1 : 100 and then stored at 4°C until just prior to use.

On the day of the test, the allergen extracts were brought to room temperature and diluted immediately in the solvent (Hengda Pharmacy Co. Ltd, Shanxi, China). Each patient received IDT using the same batch of allergen extracts. IDT was performed as follows: 10–20 μL of each allergen dilution was intradermally injected into each patient with 24–30 allergens tested at a time. Injected allergens were arranged vertically on the upper arm(s) with an interval of 2.5–3.0 cm. A positive control (histamine dihydrochloride, 10 mg/mL) and a negative control (solvent) were also included, and there was no duplicate testing. After 15 min, the size of the wheal was determined by measuring the diameter in two perpendicular directions and then halving the sum. Since bacterial proteins always exhibit a late phase reaction, those results were measured after 24 hrs. The reaction was regarded as positive if the calculated wheal diameter was more than 5 mm.

2.2. Relationship of the Allergenic Sources

To assess whether the distribution of positive reactions to each allergenic source reflects a correlation between different allergenic sources, the number of patients with positive IDT reactions to each allergenic source was counted. Patients showing multiple positive reactions to different allergenic sources were counted once for each individual allergenic source they reacted to. All the allergenic sources were ranked according to patient counts, since there may be cosensitization to different allergenic sources.

2.3. Overall Distribution of the Allergens Worldwide

The nonredundant allergen data were extracted from the IUIS allergen list (June 20, 2012) available at the website The overall research status of allergens worldwide was analyzed as follows: the number of allergenic species and the related allergen numbers within each taxonomic category were recorded. The consistency of the two distributions thereof was investigated by Kolmogorov-Smirnov test, which measures the maximum difference between two cumulative distribution functions and calculates the probability that the two observed distributions would exhibit a difference at least that large if the samples were drawn from identical populations [11]. The parameters tested are as follows: , , , , , where and denote the number of allergenic species and the number of allergenic proteins within each taxonomic category, respectively.

2.4. Clustering of Major Allergens by Amino Acid Sequences

Another set of data related to the amino acid sequences of major allergens was retrieved on June 20, 2012, by searching UniProtKB/Swiss-Prot ( using the keyword “major allergen” and was selected from the IUIS allergen list ( by IgE-binding potency. The phylogenetic relationship among the major allergens was inferred by the free package Clustal W 1.83 [12] and MEGA5.0 [13] using the alignments of the amino acid sequences. In the output tree, each single, line-linked, large, and dense group of allergens was taken as one cluster or subcluster. The uppermost allergen sequence in each large and dense cluster in the output tree was retained and taken as the core sequence, with other sequences eliminated. Progressive clustering was repeated by manual iterative selection and alignment of the core sequences. The alignment cycle was stopped when any two allergens were no longer able to be clustered into one subcluster. These allergens are hereafter referred to as “major representative allergens.”

The same clustering procedure above mentioned was applied on the corresponding allergens in which Allergen Family Featured Peptides (AFFPs) are located. AFFPs are allergen-specific peptides panned from nonredundant allergens and harbor perfect information with noise fragments eliminated because of their similarity with nonallergens. 534 AFFPs can correctly discriminate 2290 allergens at the highest sensitivity and specificity and make the underlying software SORTALLER outperform other methods at present [14], which demonstrates that 534 AFFPs have a powerful representativeness.

2.5. Comparison of the 3D Structures of the Major Representative Allergens

To compare the three-dimensional (3D) structures of the major representative allergens, the 3D structure of each major representative allergen was modeled in SWISS-MODEL workspace, a web-based integrated service dedicated to protein structure homology modeling and assessment that can be accessible via the ExPASy Bioinformatics Resource Portal [15]. The modeling results were viewed in SWISS-PdbViewer v3.7, an integrated sequence-to-structure workbench [16], followed by adjusting the presenting orientation to facilitate the comparison of the 3D structures of the different major representative allergens.

3. Results

3.1. Distribution of Positive Reactions to Allergenic Sources in Southern China

Intradermal tests using 62 allergenic sources were performed on 3,335 allergic patients. 3,084 of these patients reacted to at least one of the allergenic sources, with the positive frequency being 89.8%. All the allergenic sources used were aligned according to the number of patients with positive reactions. For convenience, the 62 allergenic sources were divided into four general groups, that is, contact allergens, food allergens, pollen allergens, and microbial allergens. The top seven most potent allergenic sources across all groups were then analyzed as to the frequency of their positive reactions when compared to the positive reactions seen with the specific allergens in any particular group. As shown in Figure 1, different allergenic sources show different degrees of positive reactions. Mites (Dermatophagoides pteronyssinus and D. farinae) were the number one allergenic source, resulting in more than 70% of the positive reactions among all the four groups. Reaction to sesame (Sesamum indicum L.) ranked second with 49.3% of the positive reactions. Spiny amaranth (Amaranthus spinosus L.), Pseudomonas aeruginosa, and house dust were next with 49.2%, 48.3%, and 44.2% of the positive reactions, respectively. In total, these five allergenic sources express 88.0% to 100% of the positive reactions when compared with microbial allergens, 90.6% to 100% when compared with food allergens, 96.3% to 100% when compared with contact allergens, and 99% to 100% when compared with pollen allergens. That is to say, these five allergenic sources are the most potent and show the most reactivity among the patients we tested; hence we have designated them as the major representative allergenic sources.

3.2. Species Distribution of Allergens Studied Worldwide

At the date of data retrieval for this study (June 20, 2012), 727 nonredundant allergens were listed in the allergen website (, relating nine categories and 241 species altogether (Figure 2). In terms of categories, foods contain the highest number of allergenic species with insects and fungi being the next most frequent. For allergenic proteins within each category, foods are also number one with fungus and insect allergens ranking second and third. Animals, weeds, and grasses possess the least number of species. In terms of species, the most abundant allergens are possessed by ragweed, timothy, olive, mite, cat, Aspergillus fumigatus, peanut, latex, and so forth. The number of allergenic species and the number of allergens in each category constitute two distributions (Figure 2). Kolmogorov-Smirnov test shows no significant statistical difference () between the number of allergenic species in each category and the number of allergens in each category (Table 1). It indicates that the two distributions were drawn from an identical population, and that the number of allergens is closely related to the number of allergenic species. That is to say, in terms of the allergen research realm worldwide, allergens evolved in parallel from one species to another; no emphasis was prescribed to a certain species/allergen.

GroupFrequenceCumulate FrequenceCumulate Frequency
Species no. Allergens no.Species no.Allergens no.Species no.Allergens no.


The allergen data analyzed were downloaded from the IUIS website ( on June 20, 2012. = Maximum , while the threshold values were , .
3.3. Progressive Clustering of the Major Allergens and AFFPs

Previously, we retrieved online 478 allergen sequences and clustered them into eight groups by sequence similarity [5]. In this study, we focused on major allergens and retrieved 280 entries, and 59 major allergens were retained after initial reduction. Clustering results showed that the 59 major allergens were initially classified into seven clusters (Figure 3(a)). Two or more neighboring clusters were combined to form a new data source for further clustering. This procedure was iterated until the last clustering exhibited 21 allergens that were distantly related to each other (Figure 3(b)). Further alignment showed that several pairs of allergens could be respectively grouped together, but with less than 15% pairwise positives in amino acid sequences and most of them exhibited different tertiary structures (See next part). Therefore, no further clustering was assigned to these allergens, and tertiary structure analysis was performed on the identified 21 major allergens.

Groups with remote homology (<20%–35% in local region) were represented by single entries. This method allowed us to reduce 534 AFFPs into 21 allergens (Figure 4) through five cycles of “cluster-selection-alignment” step, the same as that for major allergens. All the core peptides contain 3–5 matching residues with adjacent mismatches.

3.4. Overall Structure Description of the 21 Major Representative Allergens

3D structure modeling was completed for most of the above 21 allergens by an automated mode or template identification mode in a SWISS-MODEL workspace [15]. Only O82015 [17], homologous to olive allergen Ole e 1 [18], and Q01940, a major allergen Mal f 1 from Malassezia furfur [19], had no identifiable protein structures by a SWISS-MODEL search. Therefore, their 3D structures were modeled by homology to related proteins from the nearby superfamilies Q04656 [20] and O05871 [21]. The 3D structures of the 21 major representative allergens are depicted in Figure 5.

When inspected from spatial structural orientations and surface exposures of the allergens, all of the 21 allergens were shuffled against the initial clustering and interestingly fell into seven structural classes (Figure 5). However, this classification is complicated by the existence of similar structural scenarios in different structural classes.(I)Up-and-down β-barrel: includes P80384, the major allergen Lep d 2 from Fodder mite (Lepidoglyphus destructor) [22], as well as other group 2 allergens from dust mite species, for example, Der f 2 (P49278) from Dermatophagoides farinae [23].(II)β-meander and/or ψ-loop constituted calyx, shortened as β(α) calyx, such as hexagon, cradle, and globose twins: includes allergens Q01940 [19], Q9FY19 [24], P18632 [25], Q40967 [26], Q84 UI0 [27], and O82015 [17].(III)α-β structured crane: includes Q8I9R5, an allergen from Sarcoptes scabiei type hominis [28].(IV)α-β arranged banana string: includes Q95182 [29] and P43179 [30].(V)α(β) formed complex: includes P08176 [31] and Q06811 [32].(VI)α-helix built clips: a large group including P30438, P30440, P59747 [33], Q40237 [34], O04404 [35], Q9M5X7, and P16968 [36]. Interestingly, P30438 and P30440, chain 1 and chain 2 of cat allergen Fel d 1 [37], configure a pair of chiral molecules on the 3D level. O04404, Q9M5X7, and P16968, originating from different taxonomic species but classified into the same initial Cluster 7, here exhibited structures similar to each other.(VII)α-helix spiral cord: includes P01501 [38] and Q95WY0 [39], both of which came from the same initial cluster III. P01501 is an allergen Api m 3 from honeybee (Apis mellifera), also a main toxin of bee venom with strong hemolytic activity. Q95WY0 is the major oyster allergen and tropomyosin from the pacific oyster Crassostrea gigas. These two allergens exhibited similar structures but displayed different lengths of their spiral cord.

4. Discussion

There is a tight link between allergen diagnosis and immunotherapy. After obtaining the results of allergen intradermal testing, specific IgE diagnosis, and/or even challenge assays, those allergen(s) with the highest positive scores would typically be chosen for use in immunotherapy on the allergic patients. The advent of molecular biology and bioinformatics heralded an unprecedented breakthrough in the development of recombinant allergens engineered to have the same immunological characteristics as natural allergens. Many studies have therefore used recombinant allergens in place of their natural counterparts. Unfortunately, allergen screening from one species to another in parallel only displays an ostensible prosperity of allergen study and could not pinpoint the importance of each allergen. The accumulation of a large quantity of overlapping data is threatening to undermine the achievements of allergen research. Whereto allergen research goes becomes a compelling question.

Facing this question, we firstly cast a meta-analysis on 62 allergenic sources used for intradermal testing on 3,335 patients in a three-year period. The result demonstrated that 88% to 100% of the patients were cosensitized to the top five allergenic sources and assumed that these five allergenic sources would have positive immunotherapeutic effects on the majority of the patients and that the remaining allergenic sources would have minor effects on the patients when used for immunotherapy. All these data corroborate that mite, sesame (Sesamum indicum L.), spiny amaranth (Amaranthus spinosus L.), Pseudomonas aeruginosa, and house dust are the five most prevalent allergenic sources and can well represent the 62 allergenic sources identified in southern China.

Basically, each extract from a single individual allergenic source is a mixture containing about ten allergenic proteins. Certainly, house dust is a mixture as well and contains different allergenic proteins. Hence, using house dust for diagnosis is similar to general screening of allergies with allergen mixes, such as fx1, fx5, mx1, and Phadiatop of UniCAP [40]. The allergens in the top five allergenic sources hence constitute a potent and limited allergen aggregate. Besides the cross-reactivity among some allergens thereof, as deduced from the cosensitization to different allergenic sources, what their relationship is in the repertoire becomes an urgent question. Our unpublished clinical data demonstrated that the allergen preparations from either D. pteronyssinus or D. farinae can be administered to patients allergic to either mite source and can achieve similar immunotherapeutic effects, which suggests the mutual substitution of the two allergens. This result, corroborating Weber’s summary [41], also suggests that it is possible to allow the substitution of the closely related allergenic sources by major representative ones. It is tempting to further think that allergens existing in the five major allergenic sources can be reduced to fewer nonredundant and nonhomologous ones. Hence, it is crucial to converge efforts on the typical representative allergens for further research.

A systematic classification of all allergens by protein taxonomic family and even by structure has long been needed. A former study found that only 52 motifs matched 644 of 779 allergen sequences from all types of sources [42]. Mueller and colleagues argued that primary sequence comparisons could sometimes miss conserved elements of a protein, which can only be seen at the structural level, and that a comparative structural modeling approach could reveal these structural similarities undetectable at the sequence level [43]. Based on these results, the present study focused on major allergens over general ones and performed progressive clustering and manual subtraction of sequence redundancy of major allergens. Twenty-one major representative allergens were subsequently retained and were further classified into seven structural patterns, with many allergens from different sequence groups compiled in one structural class, thus validating the limitation of sequence comparison [44]. Structure class VI, for example, includes contact allergens, pollen allergens, and food allergens. Although they have low sequence homology, these allergens share similar structure scenarios with each other. Moreover, we also found that panallergen profilin (e.g., Q64LH0 [5]) exhibits a configuration of α-β-α layers (Figure 5) and is analogous to 2 EF-hand configuration (polcalcin, e.g., P59747 [33]) and even more similar if the mesial layer is replaced by an α helix-formed clip. Further analysis showed that different kinds of allergens, no matter whether they are in the same structure class or not, would share similar structure scenarios in part of their component elements. These results not only theoretically confirmed the clinical relevance between profilin and polcalcin [45], but also suggested the relevant relationship between 2 EF-hand calcium-binding proteins (P59747 [33]) and Poa p IX/Phl p VI allergen family (Q40237 [34]), cereal trypsin/alpha-amylase inhibitor family (P16968 [36]), nonspecific lipid-transfer protein (O04404 [35]), and even uteroglobin (P30438 [37]) and Ole e 1 (O82015 [17]). Major allergen Ole e 1, for example, also harbors a profilin structure-like component element (Figure 5), suggesting its panallergen characteristics [18]. All the results mentioned above are theoretically supported by remote homology modeling and protein profile comparison [46, 47] and thus have drawn a picture of a cross-reactivity network among taxonomically different allergens and even allergens with nil or low sequence similarity and explained the underlying basis of the universal existence of cosensitization to different allergenic sources by individual patients disclosed by the present study.

The 3D structures of a continuously increasing number of allergens are currently being solved. Therefore, it is possible to produce recombinant allergens that exactly mimic their natural wild types and even to produce genetically engineered hypoallergens with nil or low IgE reactivity but retained T-cell reactivity. As the present study demonstrates, clinical cosensitization to multiple allergenic sources can be attributed to a few major allergenic sources; major allergens from different species can be logically reduced to 21 major representative allergens and even grouped into 7 or less structure classes with similar structure scenarios shared by different allergens. It is tempting to think that there might not be a need to unequivocally search all the undeveloped species for totally novel allergen genes or to equivalently test numerous allergenic sources on patients. Thus, it is cost-efficient, practical, and crucial to have the recombinant allergen research focused on the major representative allergens or core AFFPs for immunotherapy strategy development and diagnosis formulation.

We recently noticed that single or fewer major allergens can not only be used to diagnose the genuine sensitization of patients to a given allergen or to the cross-sensitization to several allergenic sources, but also be used for allergen-specific immunotherapy to yield the same effects as the whole allergen mixtures in allergic patients [14, 48, 49]. Intensive clinical evidence has also proven that specific immunotherapy with one kind of allergenic reagent can prevent both the progression of allergies and the acquisition of new allergic sensitizations [50]. All these conclusions corroborate our results.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Ying He and Xueting Liu equally contributed to this study.


This work was supported by Great Project (2011ZX08011-005) from the Major Program of National Science and Technology of China and the National Natural Science Foundation of China (nos. 81373128, 81301948).


  1. F. Ferreira, T. Hawranek, P. Gruber, N. Wopfner, and A. Mari, “Allergic cross-reactivity: from gene to the clinic,” Allergy, vol. 59, no. 3, pp. 243–267, 2004. View at: Publisher Site | Google Scholar
  2. C. Radauer and H. Breiteneder, “Pollen allergens are restricted to few protein families and show distinct patterns of species distribution,” Journal of Allergy and Clinical Immunology, vol. 117, no. 1, pp. 141–147, 2006. View at: Publisher Site | Google Scholar
  3. J. A. Jenkins, S. Griffiths-Jones, P. R. Shewry, H. Breiteneder, and E. N. C. Mills, “Structural relatedness of plant food allergens with specific reference to cross-reactive allergens: an in silico analysis,” Journal of Allergy and Clinical Immunology, vol. 115, no. 1, pp. 163–170, 2005. View at: Publisher Site | Google Scholar
  4. C. Radauer, M. Bublin, S. Wagner, A. Mari, and H. Breiteneder, “Allergens are distributed into few protein families and possess a restricted number of biochemical functions,” Journal of Allergy and Clinical Immunology, vol. 121, no. 4, pp. 847–852, 2008. View at: Publisher Site | Google Scholar
  5. A.-L. Tao and S.-H. He, “Cloning, expression, and characterization of pollen allergens from Humulus scandens (Lour) Merr and Ambrosia artemisiifolia L,” Acta Pharmacologica Sinica, vol. 26, no. 10, pp. 1225–1232, 2005. View at: Publisher Site | Google Scholar
  6. J. A. Nordlee, S. L. Taylor, J. A. Townsend, L. A. Thomas, and R. K. Bush, “Identification of a Brazil-nut allergen in transgenic soybeans,” The New England Journal of Medicine, vol. 334, no. 11, pp. 688–692, 1996. View at: Publisher Site | Google Scholar
  7. U. Seppälä, C. Dauly, S. Robinson, M. Hornshaw, J. N. Larsen, and H. Ipsen, “Absolute quantification of allergens from complex mixtures: a new sensitive tool for standardization of allergen extracts for specific immunotherapy,” Journal of Proteome Research, vol. 10, no. 4, pp. 2113–2122, 2011. View at: Publisher Site | Google Scholar
  8. C. Fernández, R. Cárdenas, D. Martín et al., “Analysis of skin testing and serum-specific immunoglobulin E to predict airway reactivity to cat allergens,” Clinical and Experimental Allergy, vol. 37, no. 3, pp. 391–399, 2007. View at: Publisher Site | Google Scholar
  9. B. Qiao, “Allergen preparation and dispensing,” in Allergology, Y. Shitai, Ed., pp. 713–750, Science Press, Beijing, China, 1998 (Chinese). View at: Google Scholar
  10. W. R. Campbell and M. I. Hanna, “The determination of nitrogen by modified Kjeldahl Methods,” The Journal of Biological Chemistry, vol. 119, no. 1, pp. 1–7, 1937. View at: Google Scholar
  11. D. A. Morrow, E. M. Antman, S. A. Murphy et al., “The risk score profile: a novel approach to characterising the risk of populations enrolled in clinical studies,” European Heart Journal, vol. 25, no. 13, pp. 1139–1145, 2004. View at: Publisher Site | Google Scholar
  12. M. A. Larkin, G. Blackshields, N. P. Brown et al., “Clustal W and clustal X version 2.0,” Bioinformatics, vol. 23, no. 21, pp. 2947–2948, 2007. View at: Publisher Site | Google Scholar
  13. S. Kumar, M. Nei, J. Dudley, and K. Tamura, “MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences,” Briefings in Bioinformatics, vol. 9, no. 4, pp. 299–306, 2008. View at: Publisher Site | Google Scholar
  14. L. Zhang, Y. Huang, Z. Zou et al., “SORTALLER: predicting allergens using substantially optimized algorithm on allergen family featured peptides,” Bioinformatics, vol. 28, no. 16, pp. 2178–2179, 2012. View at: Google Scholar
  15. K. Arnold, L. Bordoli, J. Kopp, and T. Schwede, “The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling,” Bioinformatics, vol. 22, no. 2, pp. 195–201, 2006. View at: Publisher Site | Google Scholar
  16. T. Schwede, J. Kopp, N. Guex, and M. C. Peitsch, “SWISS-MODEL: an automated protein homology-modeling server,” Nucleic Acids Research, vol. 31, no. 13, pp. 3381–3385, 2003. View at: Publisher Site | Google Scholar
  17. E. Batanero, M. A. Gonzalez de la Peña, M. Villalba, R. I. Monsalve, M. Martin-Esteban, and R. Rodriguez, “Isolation, cDNA cloning and expression of Lig v 1, the major allergen from privet pollen,” Clinical and Experimental Allergy, vol. 26, no. 12, pp. 1401–1410, 1996. View at: Publisher Site | Google Scholar
  18. J. de Dios Alché, M. M'rani-Alaoui, A. J. Castro, and M. I. Rodríguez-García, “Ole e 1, the major allergen from olive (Olea europaea L.) pollen, increases its expression and is released to the culture medium during in vitro germination,” Plant and Cell Physiology, vol. 45, no. 9, pp. 1149–1157, 2004. View at: Google Scholar
  19. M. Schmidt, A. Zargari, P. Holt et al., “The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1,” European Journal of Biochemistry, vol. 246, no. 1, pp. 181–185, 1997. View at: Google Scholar
  20. M. L. Kennerson, G. A. Nicholson, S. G. Kaler et al., “Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy,” The American Journal of Human Genetics, vol. 86, no. 3, pp. 343–352, 2010. View at: Publisher Site | Google Scholar
  21. M. C. Good, A. E. Greenstein, T. A. Young, H.-L. Ng, and T. Alber, “Sensor domain of the Mycobacterium tuberculosis receptor Ser/Thr protein kinase, PknD, forms a highly symmetric β propeller,” Journal of Molecular Biology, vol. 339, no. 2, pp. 459–469, 2004. View at: Publisher Site | Google Scholar
  22. L. Kaiser, G. Gafvelin, E. Johansson, M. van Hage-Hamsten, and O. Rasool, “Lep d 2 polymorphisms in wild and cultured Lepidoglyphus destructor mites,” European Journal of Biochemistry, vol. 270, no. 4, pp. 646–653, 2003. View at: Publisher Site | Google Scholar
  23. S. Ichikawa, T. Takai, T. Inoue et al., “NMR study on the major mite allergen Der f 2: its refined tertiary structure, epitopes for monoclonal antibodies and characteristics shared by ML protein group members,” Journal of Biochemistry, vol. 137, no. 3, pp. 255–263, 2005. View at: Publisher Site | Google Scholar
  24. M. Yokoyama, M. Miyahara, K. Shimizu, K. Kino, and H. Tsunoo, “Purification, identification, and cDNA cloning of Jun a 2, the second major allergen of mountain cedar pollen,” Biochemical and Biophysical Research Communications, vol. 275, no. 1, pp. 195–202, 2000. View at: Publisher Site | Google Scholar
  25. M. Usui, A. Saito, N. Taniguchi, N. Nishijima, H. Azakami, and A. Kato, “Reduction of antigenicity of Cry j I, major allergen of Japanese cedar pollen, by the attachment of polysaccharides,” Bioscience, Biotechnology and Biochemistry, vol. 67, no. 11, pp. 2425–2430, 2003. View at: Publisher Site | Google Scholar
  26. A. Petersen, G. Schramm, A. Bufe, M. Schlaak, and W.-M. Becker, “Structural investigations of the major allergen Phl p I on the complementary DNA and protein level,” Journal of Allergy and Clinical Immunology, vol. 95, no. 5, part 1, pp. 987–994, 1995. View at: Publisher Site | Google Scholar
  27. G. López-Torrejón, G. Salcedo, M. Martín-Esteban, A. Díaz-Perales, C. Y. Pascual, and R. Sánchez-Monge, “Len c 1, a major allergen and vicilin from lentil seeds: protein isolation and cDNA cloning,” Journal of Allergy and Clinical Immunology, vol. 112, no. 6, pp. 1208–1215, 2003. View at: Publisher Site | Google Scholar
  28. K. Fischer, D. C. Holt, P. Harumal, B. J. Currie, S. F. Walton, and D. J. Kemp, “Generation and characterization of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens,” The American Journal of Tropical Medicine and Hygiene, vol. 68, no. 1, pp. 61–64, 2003. View at: Google Scholar
  29. A. Immonen, T. Kinnunen, P. Sirven et al., “The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes,” Clinical and Experimental Allergy, vol. 37, no. 6, pp. 939–947, 2007. View at: Publisher Site | Google Scholar
  30. A. Gieras, P. Cejka, K. Blatt et al., “Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1,” Journal of Immunology, vol. 186, no. 9, pp. 5333–5344, 2011. View at: Publisher Site | Google Scholar
  31. E. Adam, K. K. Hansen, O. F. Astudillo et al., “The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism,” The Journal of Biological Chemistry, vol. 281, no. 11, pp. 6910–6923, 2006. View at: Publisher Site | Google Scholar
  32. Y. Xia, H. J. Spence, J. Moore et al., “The ABA-1 allergen of Ascaris lumbricoides: sequence polymorphism, stage and tissue-specific expression, lipid binding function, and protein biophysical properties,” Parasitology, vol. 120, no. 2, pp. 211–224, 2000. View at: Publisher Site | Google Scholar
  33. M. Perez-Gordo, J. Cuesta-Herranz, A. S. Maroto et al., “Identification of sole parvalbumin as a major allergen: study of cross-reactivity between parvalbumins in a Spanish fish-allergic population,” Clinical and Experimental Allergy, vol. 41, no. 5, pp. 750–758, 2011. View at: Publisher Site | Google Scholar
  34. E. K. Ong, I. J. Griffith, R. B. Knox, and M. B. Singh, “Cloning of a cDNA encoding a group-V (group-IX) allergen isoform from rye-grass pollen that demonstrates specific antigenic immunoreactivity,” Gene, vol. 134, no. 2, pp. 235–240, 1993. View at: Publisher Site | Google Scholar
  35. R. González-Rioja, J. A. Asturias, A. Martínez, F. M. Goñi, and A. R. Viguera, “Par j 1 and Par j 2, the two major allergens in Parietaria judaica, bind preferentially to monoacylated negative lipids,” FEBS Journal, vol. 276, no. 6, pp. 1762–1775, 2009. View at: Publisher Site | Google Scholar
  36. M. Mena, R. Sanchez-Monge, L. Gomez, G. Salcedo, and P. Carbonero, “A major barley allergen associated with baker's asthma disease is a glycosylated monomeric inhibitor of insect α-amylase: cDNA cloning and chromosomal location of the gene,” Plant Molecular Biology, vol. 20, no. 3, pp. 451–458, 1992. View at: Publisher Site | Google Scholar
  37. M. Emara, P.-J. Royer, Z. Abbas et al., “Recognition of the major cat allergen fel d 1 through the cysteine-rich domain of the mannose receptor determines its allergenicity,” The Journal of Biological Chemistry, vol. 286, no. 15, pp. 13033–13040, 2011. View at: Publisher Site | Google Scholar
  38. T. Grunwald, B. Bockisch, E. Spillner, J. Ring, R. Bredehorst, and M. W. Ollert, “Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3),” Journal of Allergy and Clinical Immunology, vol. 117, no. 4, pp. 848–854, 2006. View at: Publisher Site | Google Scholar
  39. P. S. C. Leung and K. H. Chu, “cDNA cloning and molecular identification of the major oyster allergen from the Pacific oyster Crassostrea gigas,” Clinical and Experimental Allergy, vol. 31, no. 8, pp. 1287–1294, 2001. View at: Publisher Site | Google Scholar
  40. C. Nilsson, G. Lilja, M. Nordlund, M. Berthold, and M. P. Borres, “Phadiatop Infant detects IgE-mediated diseases among pre-school children: a prospective study,” Pediatric Allergy and Immunology, vol. 23, no. 2, pp. 160–166, 2012. View at: Publisher Site | Google Scholar
  41. R. W. Weber, “Cross-reactivity of pollen allergens: recommendations for immunotherapy vaccines,” Current Opinion in Allergy and Clinical Immunology, vol. 5, no. 6, pp. 563–569, 2005. View at: Google Scholar
  42. M. B. Stadler and B. M. Stadler, “Allergenicity prediction by protein sequence,” The FASEB Journal, vol. 17, no. 9, pp. 1141–1143, 2003. View at: Google Scholar
  43. J. L. Mueller, D. R. Ripoll, C. F. Aquadro, and M. F. Wolfner, “Comparative structural modeling and inference of conserved protein classes in Drosophila seminal fluid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 37, pp. 13542–13547, 2004. View at: Publisher Site | Google Scholar
  44. J. Peng and J. Xu, “Low-homology protein threading,” Bioinformatics, vol. 26, no. 12, pp. i294–i300, 2010. View at: Publisher Site | Google Scholar
  45. R. Barderas, M. Villalba, C. Y. Pascual, E. Batanero, and R. Rodríguez, “Profilin (Che a 2) and polcalcin (Che a 3) are relevant allergens of Chenopodium album pollen: isolation, amino acid sequences, and immunologic properties,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1192–1198, 2004. View at: Publisher Site | Google Scholar
  46. M. Nielsen, C. Lundegaard, O. Lund, and T. N. Petersen, “CPHmodels-3.0-remote homology modeling using structure-guided sequence profiles,” Nucleic Acids Research, vol. 38, supplement 2, pp. W576–W581, 2010. View at: Publisher Site | Google Scholar
  47. Y. Wang, R. I. Sadreyev, and N. V. Grishin, “PROCAIN: protein profile comparison with assisting information,” Nucleic Acids Research, vol. 37, no. 11, pp. 3522–3530, 2009. View at: Publisher Site | Google Scholar
  48. C. Möbs, C. Slotosch, H. Löffler, T. Jakob, M. Hertl, and W. Pfützner, “Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation,” Journal of Immunology, vol. 184, no. 4, pp. 2194–2203, 2010. View at: Publisher Site | Google Scholar
  49. M. Bublin, M. Pfister, C. Radauer et al., “Component-resolved diagnosis of kiwifruit allergy with purified natural and recombinant kiwifruit allergens,” Journal of Allergy and Clinical Immunology, vol. 125, no. 3, pp. 687–694, 2010. View at: Publisher Site | Google Scholar
  50. M. Pifferi, G. Baldini, G. Marrazzini et al., “Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study,” Allergy, vol. 57, no. 9, pp. 785–790, 2002. View at: Publisher Site | Google Scholar

Copyright © 2014 Ying He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.